Immunodysregulation of HIV disease at bone marrow level

Antonella Isgrò, Alessandro Aiuti, Wilma Leti, Claudia Gramiccioni, Antonella Esposito, Ivano Mezzaroma, Fernando Aiuti

Research output: Contribution to journalArticlepeer-review


Hematological abnormalities frequently occur in patients infected with HIV-1. Increasing evidence indicates that bone marrow (BM) suppression results from viral infection of accessory cells, with impaired stromal function and alteration of hematopoietic growth factor network. We investigated the effects of antiretroviral therapy on cytokine and chemokine production by BM cells and stromal cells, in a group of HIV-1-infected subjects before and during treatment. Compared with uninfected controls, an altered cytokine and chemokine production by BM cells has been observed before treatment, characterised by decreased IL-2 and elevated TNF-α, MIP-1α, MIP-1β, and RANTES levels, along with a defective BM clonogenic activity. Antiretroviral therapy determined an amelioration of stem cell activity, a restoration of stromal cell pattern and functions, and an increased IL-2 production at BM level and a decrease of Fas expression on progenitor cells, in parallel with the diminution of TNF-α levels. HIV-1 protease inhibitors (PIs) may improve hematopoietic functions owing to their direct effects on the BM progenitor cells. Ritonavir and indinavir increased the colony growth of BM obtained either from HIV-1-infected patients or from normal individuals, in parallel with the normalization of functional and morphologic characteristics of stromal cells.

Original languageEnglish
Pages (from-to)486-490
Number of pages5
JournalAutoimmunity Reviews
Issue number8
Publication statusPublished - Nov 2005


  • Bone marrow
  • Cytokine
  • HIV
  • Stromal cells

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Fingerprint Dive into the research topics of 'Immunodysregulation of HIV disease at bone marrow level'. Together they form a unique fingerprint.

Cite this